The 13th ASIA PHARMA EXPO 2022 (APE 2022) & ASIA LAB EXPO 2022, international exhibitions on complete pharma manufacturing technologies concluded at ICCB, Dhaka, Bangladesh. The 3-day exhibition was held from May 19 to 21, 2022 at Dhaka.
The exhibition celebrated 20 highly successful years in Bangladesh and helping to develop the pharmaceutical industry of Bangladesh and making significant contribution to Bangladesh economy.
BAPI President, Nazmul Hassan, MP inaugurated the exposition as the Chief Guest. Director General of Drug Administration (DGDA) Major General Mohammad Yousuf was the Chief Guest and high officials from various pharma companies were also present.
In his inaugural speech, Nazmul Hassan said, “Asia Pharma Expo continues to play a very important role by providing great insights into current industry trends and developments, and opening up new opportunities for all the stakeholders from around the world.”
At Asia Pharma Expo 2022 / Asia Lab Expo 2022, more than 387 exhibiting companies from 24 countries across the world exhibited and displayed their latest products / services to upgrade the pharma manufacturing standards of Bangladesh to a newer height. The 2022 edition was attended by 11,934 trade visitors to explore the complete spectrum of latest pharma manufacturing technologies and services. The trade professionals attended the exhibition represented Pharmaceuticals, Healthcare, Biotech, API, Neutraceuticals, Personal Care, Cosmetics, Beverages, Distilleries segments from the industry.
Asia Pharma Expo and Asia Lab Expo have been jointly organized by the Bangladesh Association of Pharmaceutical Industries and GPE Expo Pvt Ltd at Dhaka, Bangladesh since 2003, offering an unparalleled international business and technologies platform specifically to the entrepreneurs and the corporate giants manufacturing and exporting the pharma medicines globally. The exhibitions are nurturing the growth by empowering the local pharma and allied manufacturing industries on technological aspects to scale up the manufacturing practices. An overwhelming response by the local Business Associates as well technology solution providers from outside Bangladesh was noticed.
The pharmaceutical sector of Bangladesh is progressing multifold. Apart from meeting the domestic demands of pharma formulations, the pharma industry is also earning huge foreign exchange from the exports.
With the existing market value of about USD 3 billion, the Bangladesh pharma manufacturing industry is rapidly marching ahead with great potential as 98% of the country’s total demand for medicine is being met by nearly 300 domestic manufacturers, which is a milestone in the history of the Bangladesh pharmaceutical industry. At the same time, these local manufacturers are exporting as well to more than 127 countries across the world.
The anticipated market size of the Bangladesh pharmaceutical industry is more than USD 6 billion by 2025 with an absolute growth of 114% from 2019 levels, while the pharma exports of Bangladesh is likely to cross USD 450 Million by 2025. The share of the local manufacturing companies is above 90%.